Who Owns XBiotech Stock?
NASDAQ: XBITHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 6.74%
- Held by insiders
- 36.87%
- Institutional holders
- 52
- Institutions 6.7%
- Insiders 36.9%
- Public and other 56.4%
Who owns XBiotech stock?
Institutional investors own about 6.7% of XBiotech's shares, spread across 52 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 36.87% of XBIT.
The largest institutional holders are Blackrock Inc. (1.05%), Geode Capital Management, LLC (0.70%) and Vanguard Capital Management LLC (0.66%). Together, the top 10 institutions control 4.9% of shares outstanding. In their latest filings, 2 of the top 10 institutions increased their XBIT positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of XBIT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 321.15K | 1.05% | +9.6% |
| Geode Capital Management, LLC | 214.12K | 0.70% | -7.3% |
| Vanguard Capital Management LLC | 200.18K | 0.66% | -0.4% |
| RBF Capital, LLC | 198.50K | 0.65% | 0.0% |
| Morgan Stanley | 147.88K | 0.49% | -10.7% |
| Bridgeway Capital Management, LLC | 98.45K | 0.32% | 0.0% |
| Vanguard Fiduciary Trust Co | 92.36K | 0.30% | +0.9% |
| Millennium Management Llc | 79.33K | 0.26% | -24.8% |
| State Street Corporation | 73.01K | 0.24% | 0.0% |
| Northern Trust Corporation | 66.26K | 0.22% | -12.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of XBIT
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 200.18K | 0.66% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 94.74K | 0.31% |
| iShares Trust-iShares Micro-Cap ETF | 78.07K | 0.26% |
| EA Series Trust-EA Bridgeway Omni Small-Cap Value ETF | 59.55K | 0.20% |
| Bridgeway Funds, Inc.-Ultra-Small Company Fund | 38.90K | 0.13% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 35.15K | 0.12% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 27.51K | 0.09% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 15.48K | 0.05% |
| American Century ETF Trust-Avantis U.S. Small Cap Equity ETF | 13.23K | 0.04% |
| JNL Series Trust-JNL/DFA U.S. Small Cap Fund | 6.07K | 0.02% |
Frequently asked questions
Who is the largest shareholder of XBiotech?
Blackrock Inc. is the largest institutional shareholder of XBIT, owning 1.05% of shares outstanding (321.15K shares) as of its latest 13F filing.
What percentage of XBiotech is owned by institutions?
Institutions own about 6.7% of XBIT shares and 10.7% of the public float.
How much of XBiotech do insiders own?
Insiders, such as officers and directors, own about 36.87% of XBIT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.